Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: With the growing popularity of total ankle arthroplasty (TAA), there is an expectation that revision surgeries will increase. However, limited data exist on revision TAA outcomes using a revision-specific implant. The INVISION Total Ankle Revision System is a modular revision implant (Wright Medical Group/Stryker). The purpose of this study was to report implant survivorship, complications, and radiographic and clinical outcomes of revision TAA using the INVISION system at a minimum 2-year follow-up.
Methods: A retrospective review was conducted of 27 patients that underwent a revision TAA using the INVISION implant at a single institution with minimum 2-year follow-up between 2016 and 2020. Implant survivorship was the primary outcome. Demographics, complications, reoperation, and radiographic and clinical outcomes were recorded.
Results: Implant survivorship was 81.5% (22/27) at a mean of 3.6 years following revision TAA using the INVISION implant. There was evidence of aseptic loosening in 3 patients and talar subsidence in 4 patients on final radiographs. Reoperation rate at final follow-up was 40.7%, most commonly for aseptic loosening (n = 3), septic TAA (n = 2), or gutter impingement (n = 2). The mean American Orthopaedic Foot & Ankle Society (AOFAS) total score was 54.5, Foot and Ankle Ability Measure (FAAM) activities of daily living (ADL) subscale score was 52.9, and FAAM Sports was 31.0.
Conclusion: Revision TAA using the INVISION implant demonstrated 81.5% implant retention at a mean of 3.6 years in this complex cohort. Patient-reported outcomes were lower than those reported after primary TAA. Physicians and patients should recognize that revision TAA remains a challenging procedure with a high rate of complications and reoperations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/10711007251352529 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
TLR-4/Notch1/NF-κB pathway modulation by dapagliflozin: a novel mechanism for neuroprotection in hepatic encephalopathy.
Metab Brain Dis
September 2025
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Acute or chronic liver damage can result in Hepatic Encephalopathy (HE), a potentially fatal neuropsychiatric condition that leads to cerebral and neurological alterations. Dapagliflozin (DAPA), an orally active Sodium/Glucose cotransporter 2 inhibitor with long duration of action. The study aim was to evaluate the potential protective impact of DAPA against HE caused by Thioacetamide (TAA) in rats.
View Article and Find Full Text PDFAnterior Approach Total Ankle Arthroplasty with Patient-Specific Cut Guides.
JBJS Essent Surg Tech
August 2025
Department of Orthopaedics, Faculty of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Background: Over the last 30 years, total ankle arthroplasty (TAA) has become a viable surgical option for end-stage ankle arthritis. The aim of TAA is to relieve pain and preserve ankle joint range of motion, which, by definition, shields adjacent joints. Alignment is essential for the longevity and survival of TAA, since malalignment of TAA components can cause abnormal loading patterns with subsequent polyethylene wear and early implant failure.
View Article and Find Full Text PDFComparison of Early Postoperative Complications and Work Relative Value Units-Based Compensation After Primary Versus Revision Total Ankle Arthroplasty.
J Am Acad Orthop Surg
August 2025
From the Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago, Chicago, IL (Lee), and the Geisinger Commonwealth School of Medicine, Scranton, PA (McDonald).
Background: Total ankle arthroplasty (TAA) has been increasingly used to treat end-stage of ankle arthritis, leading to a corresponding rise in revision TAA (rTAA). Given the greater complexity of rTAA procedures, assessing whether early postoperative complications differ from primary TAA and whether current reimbursement models appropriately account for this complexity remains essential.
Methods: Using the National Surgical Quality Improvement Program database from 2013 to 2022 and current procedural terminology codes, patients undergoing TAA or rTAA were identified.
Failure Rate of Fixed Versus Mobile Bearing Total Ankle Arthroplasty.
J Am Acad Orthop Surg
August 2025
From the Department of Orthopaedics & Physical Medicine, Medical University of South Carolina, Charleston, SC (Nadeau, Ottofaro, Morningstar, Gross, and Scott), and the University of North Carolina School of Medicine, Chapel Hill, NC (Morningstar).
Background: With an increasing number of total ankle arthroplasties (TAAs) being performed and an abundance of new survivorship data available, an updated literature review is needed to better understand the impact of different types of implants on outcomes of TAA. This study aims to review existing literature and identify trends among current individual fixed versus mobile bearing TAA implants.
Methods: A comprehensive search of PubMed, CINAHL, and Scopus for all articles published between 2004 and 2024 examining outcomes of third- and fourth-generation TAAs was conducted with a minimum 2-year mean follow-up.
Implant Survivorship and Radiographic Outcomes of Revision Total Ankle Arthroplasty Using a Modular Revision System.
Foot Ankle Int
July 2025
OrthoCarolina Foot & Ankle Institute, Charlotte, NC, USA.
Background: With the growing popularity of total ankle arthroplasty (TAA), there is an expectation that revision surgeries will increase. However, limited data exist on revision TAA outcomes using a revision-specific implant. The INVISION Total Ankle Revision System is a modular revision implant (Wright Medical Group/Stryker).
View Article and Find Full Text PDF